v3.25.4
INVESTMENT IN BC THERAPEUTICS INC. (Tables)
6 Months Ended
Jan. 31, 2026
Investments, All Other Investments [Abstract]  
SCHEDULE OF CHANGES IN INVESTMENT

Changes in the Company’s equity investment in BC Therapeutics is summarized as follows:

 

Balance – August 1, 2024  $418,490 
Funding (including the value of the BC Therapeutics Options)   330,000 
Share of losses   (224,212)
Balance – July 31, 2025   524,278 
Funding (including the value of the BC Therapeutics Options)   165,000 
Share of losses   (106,823)
Balance – January 31, 2026  $582,455 
SCHEDULE OF ASSETS AND LIABILITIES OF BC THERAPEUTICS

The following amounts represent the Company’s 67.8% share of the assets of BC Therapeutics (July 31, 2025 – 63.1%):

 

  

As of

January 31, 2026

 
Current assets: Cash  $1,400 
Net assets  $1,400